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aBstraCt
The ocular ischemic syndrome (OIS) is a rare condition with vision-threatening potentials. It is characterized by 
chronic ischemia of the anterior and/or posterior segment of the eye primarily caused by severe carotid artery occlu-
sive diseases. In this article, we present a case of a 67-year-old male patient presented with the gradual diminution of 
vision in the right eye for 6 months. The patient had undergone a right internal carotid artery (ICA) endarterectomy 
(CEA) twice before. On the day of admission, intraocular pressure (IOP) was 34 mm Hg in the right eye (RE) and 
20 mm Hg in the left eye (LE). On anterior segment examination, neovascularization of iris in the right eye was 
noted. On fundoscopy dilated retinal veins, attenuated retinal arteries, blot hemorrhages, cotton wool spots and mic-
roaneurysms were present. The patient underwent the appropriate investigations including computed tomography 
angiography (CTA) of carotid arteries, fundus fluorescence angiography (FFA) and Doppler ultrasound (DUS) of 
ophthalmic and central retinal arteries, which were all consistent with a diagnosis of bilateral OIS. Intraocular pres-
sure was pharmacologically reduced and stabilized. Subsequently, panretinal photocoagulation (PRP) of peripheral 
capillary nonperfusion areas was performed in both eyes.
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introduCtion
The ocular ischemic syndrome (OIS) is caused 
by arterial hypoperfusion of the eye due to severe 
stenosis or occlusion of the ipsilateral common or 
internal carotid artery (ICA) [1, 2]. The reported 
incidence is 7.5 cases per million persons every year 
[3]. The average age of patients with OIS is 65 and 
it is rarely diagnosed among people before the age 
of 50 [2]. This condition is twice as common in 
men due to the higher incidence of cardiovascular 
and atherosclerotic diseases compared to women [3, 
4]. Other risk factors include hypertension, hyper-
lipidemia, uncontrolled diabetes mellitus, smoking 
addiction and vasculitis [4]. Loss of vision is usually 
unilateral and progresses slowly. However, there are 
cases of sudden blindness [1]. In about 20% of 
cases, bilateral IOS occurs [3], which more often 
affects patients with the aortic arch syndrome, hy-
perhomocysteinemia and Takayasu arteritis [2, 5].
Visual loss of varying degree is the most com-
mon symptom [4]. Changes of the anterior segment 
include conjunctival and episcleral injection, rube-
osis iridis, secondary neovascular glaucoma, iridocy-
clitis, iris atrophy, anterior and posterior synechiae, 
sluggish pupillary reaction to light, corneal edema 
with Descemet’s folds, asymmetric cataract. More 
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characteristic are changes related to the posterior 
segment, such as narrowed retinal arteries, dilated 
but not tortuous retinal veins, neovascularization of 
the optic disc and the retina, perifoveal telangiecta-
sias, retinal hemorrhages, microaneurysms, cotton 
wool spots, areas of chorioretinal atrophy, macular 
edema or vitreous hemorrhage. These symptoms 
may co-occur with the orbital infarction syndrome, 
which includes ophthalmoplegia, orbital pain, hy-
potony and ptosis [1, 2, 4, 6]. 
The aim of this study was to present a case of 
a progressive bilateral ocular ischemic syndrome de-
spite previously performed carotid endarterectomy.
Case report
A 67-year-old male presented to the emergency 
room complaining of recurrent unilateral eye pain 
and gradual decrease and blurring of the vision in 
his right eye for the past 6 months. His medical his-
tory included hypertension, coronary artery disease, 
hypercholesterolemia, type 2 diabetes mellitus and 
diabetic nephropathy. 
He underwent artery bypass surgery nine years 
ago, percutaneous coronary intervention three years 
ago. He had twice undergone an ICA endarterec-
tomy (in 2017 and 2018). There was no history of 
ocular or head trauma.
At the time of presentation, the best-corrected 
visual acuity (BCVA) was 5/50 in the RE and 5/8 in 
the LE.  Anterior segment examination showed con-
junctival injection and anterior synechiae in both 
eyes. The pupil in the RE was semi-dilated and 
non-reactive. Moreover, in the RE, there was ad-
vanced iris neovascularization and the presence of 
new vessels in the iridocorneal angle on gonioscopy. 
Fundus examination in both eyes showed attenuat-
ed retinal arteries, dilated retinal veins, cotton-wool 
spots, microaneurysms and blot hemorrhages at the 
retinal mid-periphery (Fig. 1). Intraocular pressure 
was 34 mm Hg in the RE and 20 mm Hg in the LE 
on applanation tonometry. The patient was admit-
ted to the Department of Ophthalmology to reduce 
IOP and for further work-up. 
Computed tomography angiography (CTA) of 
carotid arteries revealed critical narrowing (over 
90%) of the proximal segment of the right inter-
nal and external carotid arteries, confirming that 
the patient had developed carotid artery restenosis 
after his previous carotid endarterectomies (CEAs). 
Moreover, the CTA showed narrowing 60% of the 
proximal segment of the left ICA and occlusion of 
the right vertebral artery. There were no changes 
inside the orbital cavities that could lead to pressure 
on the blood vessels and ischemia of the eyeballs for 
reasons other than atherosclerosis.
Fundus fluorescence angiography (FFA) of 
the RE revealed prolonged arm-to-choroid and 
arm-to-retina circulation time, arteriovenous tran-
sit time delay, extensive non-perfusion areas within 
the peripheral retina, staining of the retinal vessels 
at the late phase and hyperfluorescence of the optic 
disc (Fig. 2). In the LE, non-perfusion zones in 
the temporal quadrants and macular edema were 
seen. Microaneurysms were also noted in both eyes 
(Fig. 3). This picture suggested diabetic retinopathy 
of both eyes. However, significant asymmetry of 
ischemic changes more strongly marked in the RE 
indicated OIS.
Doppler ultrasound (DUS) examination showed 
high retrograde flows in both ocular arteries (OA) 
(Fig. 4). Whereas in the central retinal arteries, the 
Figure 1aB. Fundus photographs of the right and left eye: dilated but not tortuous retinal veins, narrowed retinal arteries, cotton wool 
spots, microaneurysms and retinal hemorrhages at the mid-periphery
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flows were disturbed, and the resistances increased 
(Tab. 1). 
Due to the poor view of the fundus, optical 
coherence tomography (OCT) could not be per-
formed. Complete blood count (CBC), erythro-
cyte sedimentation rate (ESR), C-reactive protein 
(CRP), coagulogram, and lipid profile were with-
in normal limits. In contrast, fasting blood sugar 
(FBS) was 193 mg/dL (normal: 70–99 mg/dL), and 
glycated hemoglobin (HBA1c) level was 6.8% (the 
norm in properly managed diabetes is up to 7%).
Based on the above findings, the patient was 
diagnosed with bilateral OIS. Treatment with topi-
cal b-adrenergic blocker and a2-agonists along with 
carbonic anhydrase inhibitors was included, result-
ing in reduction and stabilization of IOP. Then, he 
was planned for panretinal photocoagulation (PRP) 
a
B
C
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Figure 2a-d. aFF of the right fundus: delayed arterial phase (0:28), foci of blocked fluorescence from cotton-wool spots, hyperfluorescence 
of the microaneurysms, extensive non-perfusion zones at the periphery (1:33), hyperfluorescence of the optic disc, non-perfusion zones  
at the periphery (2:44), and staining of the retinal vessels at the late phase (6:48)
Figure 3. aFF of the left fundus: macular edema, microaneurysms, 
and peripheral non-perfusion zones (5:20)
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of peripheral capillary nonperfusion areas in both 
eyes. The procedure was performed in a typical way, 
without complications. The man was discharged 
from the hospital and informed about the need for 
further treatment of vascular changes as a matter of 
urgency by the vascular surgeon, cardiologist, neu-
rologist due to the threat of vision in both eyes, as 
well as the diabetologist in order to stabilize blood 
glucose level. At the 3-month clinical follow-up, 
BCVA was still 5/50 in the RE and 5/8 in the LE.  
disCussion
In patients with OIS, a narrowing of the internal 
or common carotid arteries 90% or more is usually 
present on the same side as the symptoms. In half of 
the cases, complete occlusion is detected. Less often, 
the symptoms are caused by the occlusion of OA. 
There is a greater chance of developing OIS if the 
patient has poorly developed collateral circulation 
between the internal and external carotid arteries or 
between the two ICAs. In such circumstances, even 
a 50% stenosis can cause OIS [1, 6, 7].
Atherosclerosis, progressing with age and/or due 
to dyslipidemia, is a major factor in sclerosis and 
stenosis of the carotid arteries resulting in ocular 
hypoperfusion [1, 2]. Other causes include dis-
secting aneurysm of the carotid artery, aortic arch 
syndrome, giant cell arteritis, Takayasu arteritis, Be-
hcet’s disease, fibrovascular dysplasia, trauma or in-
flammation causing stenosis of the carotid arteries as 
well as complications after intravitreal anti vascular 
endothelial growth factor (anti-VEGF) injections 
or after radiotherapy for nasopharyngeal carcinoma 
[1, 3, 8–10].
Often, asymptomatic onset (pain occurs in 
about 40% of cases) [1], as well as a wide and com-
plex spectrum of ophthalmic symptoms causes that 
many patients with OIS remain undiagnosed or 
misdiagnosed, which may later contribute to irre-
versible loss of vision, as well as increased mortality 
[2, 3, 6]. Imaging studies of the carotid arteries play 
a key role in diagnosing OIS. Among them, the 
most common and non-invasive method is DUS 
of carotid arteries. CTA or, less often, magnetic 
resonance angiography are also used. Moreover, 
a useful test is DUS of retrobulbar vessels, in which 
decreased or reversed blood flow in the OA can be 
seen. Reversed blood flow in the OA arises when, 
as a result of the coexistence of severe ICA stenosis 
and incomplete blood circulation in the circle of 
Wills, the blood flow in the OA reverses to supply 
the ipsilateral brain. It is otherwise referred to as 
“steal-phenomenon” and leads to reduced retrob-
ulbar blood flow, hypoperfusion and ischemia of 
ocular tissues. It is a highly specific indicator of 
ipsilateral stenosis or occlusion of ICA [1, 6].
 Another test used in the diagnosis of OIS is 
FFA, where delayed arm-to-choroid and arm-to-ret-
ina circulation time is a common symptom. In al-
most 60% of cases, patchy or delayed choroidal 
table 1. doppler ultrasound (dus) of central retinal 
arteries in both eyes
re Le
Vmax 1.2 cm/s 12.9 cm/s
Vmin 2.5 cm/s 2.8 cm/s
pI 1.63 1.57
rI 0.8 0.77
re — right eye; Le — left eye; Vmax — maximal velocity; Vmin — minimal velocity; 
pI — pulsatility index; rI — resistance index
Figure 4. Color-coded duplex ultrasonography (toshiba Xario, Model SSa-660a, tokyo, Japan): a. Doppler signal of an inverted right 
ophthalmic artery flow due to right ICa stenosis (over 90%) showing negative velocities; B. Doppler ultrasound (DUS) of right central  
retinal artery
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filling time occurs, which is the most specific angi-
ographic sign of OIS. However, the most sensitive 
angiographic sign of OIS (present in up to 95% of 
patients) is prolonged retinal arteriovenous time [1, 
3]. Another common angiographic sign (observed 
in 85% of cases) is staining of the retinal vessels 
(primarily arteries) due to their increased perme-
ability induced by endothelial cell damage because 
of chronic ischemia. In addition, hyperfluorescence 
of the optic disc is caused by leaks from disc capil-
laries. Moreover, cotton wool spots, edema of the 
nerve fiber layer of the optic disc and choroidal atro-
phy can also appear due to choroidal vascular com-
promise [1]. FFA can show the presence of micro-
aneurysms around the macula or at the mid-periph-
ery [11], as well as retinal capillary non-perfusion 
found mostly at the mid-periphery [3]. Indocyanine 
green angiography (ICG) is also helpful in assess-
ing choroidal vascular abnormalities in eyes with 
OIS [1, 2]. Furthermore, enhanced depth imaging 
optical coherence tomography (EDI-OCT) shows 
choroidal thinning and smaller luminal and stromal 
area in people with OIS or with significant stenosis 
of the carotid arteries [6, 12].
Differential diagnosis of IOS should primarily 
include moderately advanced central retinal vein 
occlusion (CRVO) and diabetic retinopathy (DR), 
then the hyperviscosity syndromes or autoimmune 
uveitis. Absence of tortuous retinal vein and some-
times retinal artery pulsations present in OIS help 
to distinguish it from CRVO. Cotton wool spots 
can be found in both OIS and DR. However, more 
intraretinal hemorrhages and the presence of hard 
exudates suggest diabetic etiology, while it should 
be borne in mind that DR and OIS may co-occur. 
Therefore, patients with asymmetric retinopathy 
should be examined for possible carotid artery ste-
nosis. During FFA, the lack of retinal arterial stasis 
and choroidal filling defects in CRVO and DR al-
lows them to be differentiated from OIS [2, 3].
The most dangerous effect of chronic retinal 
and choroidal ischemia is the increased production 
of VEGF, which causes neovascularization in the 
anterior (iris, iridocorneal angle) as well as posterior 
segment (retina, optic disc). Changes in the anterior 
segment may lead to the development of neovascu-
lar secondary glaucoma. At the early stages of glau-
coma, topical b-adrenergic blockers or a2-agonists 
along with carbonic anhydrase inhibitors are mainly 
used to reduce IOP. Prostaglandin analogues, how-
ever, due to their potential pro-inflammatory ef-
fects, should not be used when neovascularization 
is accompanied by inflammation. Pilocarpine is also 
not recommended, as it may lead to posterior syn-
echiae and increase occlusion of the iridocorneal an-
gle. Moreover, it is also recommended to use mydri-
atics. [1, 2]. Trabeculectomy should be considered 
for patients not responding to drug treatment, with 
limited angle neovascularization and preserved VA. 
If this procedure is ineffective or significant angle 
neovascularization is present, it is recommended to 
implant aqueous shunt implants [2, 13]. In the pos-
terior segment, new vessels are more often formed 
at the optic disc than in the retina. They can cause 
bleeding, result in hemorrhages into the vitreous 
body and fibrovascular proliferation. To inhibit the 
formation of new vessels, PRP is performed. How-
ever, it should be noted that the effectiveness of this 
procedure is only 36% (because choroidal ischemia 
alone, without accompanying retinal ischemia, can 
induce neovascularization) and it does not show 
any promising effect in the visual outcome [1, 2]. 
Moreover, there are studies on the use of anti-VEGF 
injections to treat neovascular glaucoma and macu-
lar edema associated with OIS [14].
Surgical treatments for carotid artery stenosis 
include CEA, which is 70–90% effective for symp-
tomatic and 60% for asymptomatic patients [15]. 
An alternative treatment method is carotid artery 
stenting (CAS). However, with total occlusion, ar-
terial by-pass surgery remains the only treatment 
option [1, 16]. Restoration of normal blood flow, 
especially before the onset of iris neovasculariza-
tion and secondary glaucoma, allows stabilization 
of existing VA. Performing the surgery at an early 
stage of the development of neovascularization may 
in turn contribute to the regression of changes that 
have already developed at the angle. However, it 
should be borne in mind that after revascularization 
surgery, as a result of increased oxygen distribu-
tion and re-production of aqueous humor by the 
ciliary body, IOP may increase [2, 3, 16]. The case 
described by us shows that despite proven high ef-
fectiveness, CEA is not always able to protect the 
patient from restenosis and OIS, which other au-
thors have also encountered [17, 18].
In 29% of patients, symptomatic carotid ste-
nosis co-occurs with changes in the retinal arteries, 
often without any symptoms, and 1.5% per year 
progress to symptomatic OIS. On the other hand, 
it is assumed that OIS may occur as the first symp-
tom of ICA occlusion in 69% of patients [19]. 
According to Hayreh et al. [20], the incidence of 
myocardial ischemia before or after the onset of 
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OIS was 22%, whereas the incidence of transient 
ischemic attack (TIA)/stroke was 17%. Further-
more, given that the 5-year survival rate in patients 
with OIS is only 60% [4, 21], it is extremely im-
portant for patients with OIS to have a neurologi-
cal, cardiological and vascular surgical consultation 
as soon as possible to minimize the risk of morbid-
ity and mortality.
ConCLusion
OIS is a rare condition associated with systemic 
diseases and can result in irreversible vision loss as 
well as increased mortality rate. In the case where 
OIS is the first symptom of  significant stenosis of 
the carotid arteries, the role of an ophthalmologist 
is extremely important and consists not only in 
making the right and early diagnosis and initiating 
appropriate treatment but also in cooperation with 
other specialists to prevent cerebrovascular and car-
diovascular complications. 
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